|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows (used in) provided by operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities | |||||
| Decrease in other current assets | |||||
| Increase (decrease) in accrued expenses and other current liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from financing activities: | |||||
| Preferred stock dividend payments | |||||
| Net cash used in financing activities | |||||
| Net decrease in cash | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Non-cash financing activities: | |||||
| Declaration of dividend for Series C Preferred Stock | |||||
| Accretion of 5% liquidation preference for Series C Preferred Stock | |||||
Loading...